title: Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.
authors.forename: M D
authors.initials: MD
authors.lastname: Hagen
authors.forename: A M
authors.initials: AM
authors.lastname: Garber
authors.forename: S J
authors.initials: SJ
authors.lastname: Goldie
authors.forename: J E
authors.initials: JE
authors.lastname: Lafata
authors.forename: J
authors.initials: J
authors.lastname: Mandelblatt
authors.forename: D
authors.initials: D
authors.lastname: Meltzer
authors.forename: P
authors.initials: P
authors.lastname: Neumann
authors.forename: J E
authors.initials: JE
authors.lastname: Siegel
authors.forename: H C
authors.initials: HC
authors.lastname: Sox
authors.forename: J
authors.initials: J
authors.lastname: Tsevat
mesh_terms: D003362:Cost-Benefit Analysis; D003955:Diagnostic Tests, Routine / Q000191:economics*; D005260:Female; D006801:Humans; D016134:Organizational Policy; D065006:Papanicolaou Test; D019057:Quality-Adjusted Life Years; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control*; D014626:Vaginal Smears / Q000191:economics*